Sclerosing stromal tumor of the ovary
Updates to Article Attributes
A sclerosingSclerosing stromal tumour (SST) of the ovary is a rare ovarian neoplasm. It is considered a sub type of ovarian stromal tumour.
Epidemiology
It occurs predominantly in young women (peaks, peaks around 2nd to 3rd decades of life)1-2.
Clinical presentation
Patients may have menstrual irregularity and / or/or pelvic pain 4.
Pathology
It is histologically characterized by cellular heterogeneity, prominent vasculature, and a pseudolobular appearance composed of cellular and hypocellular areas.
They generally tend to be unilateral 3.
Radiographic features
Ultrasound
Described sonographic features (whilst being non specific) include tumour with multi-locular cystic components and irregularly thickened septa and tumor walls or a solid tumor including several small cystic components 5.
Pelvic MRI
Described signal characteristics include 5
-
T2:
- signal intensities of the cystic components were high and those of the solid components were inhomogeneous, ranging from intermediate-high to high
. - MR may show pseudolobulation 7-8 of the lesion which consists of low-intensity nodules set against high-intensity stroma on T2-weighted images 7
- signal intensities of the cystic components were high and those of the solid components were inhomogeneous, ranging from intermediate-high to high
-
dynamic MRI: may show marked early enhancement of the solid components 5,7
.
See also
-<p>A <strong>sclerosing stromal tumour (SST) of the ovary</strong> is a rare ovarian neoplasm. It is considered a sub type of <a href="/articles/ovarian-stromal-tumour" title="ovarian stromal tumour">ovarian stromal tumour</a>.</p><h4>Epidemiology</h4><p>It occurs predominantly in young women (peaks around 2<sup>nd</sup> to 3<sup>rd</sup> decades of life)<sup> 1-2</sup>. </p><h4>Clinical presentation</h4><p>Patients may have menstrual irregularity and / or pelvic pain <sup>4</sup>.</p><h4>Pathology</h4><p>It is histologically characterized by cellular heterogeneity, prominent vasculature, and a pseudolobular appearance composed of cellular and hypocellular areas.</p><p>They generally tend to be unilateral <sup>3</sup>.</p><h4>Radiographic features </h4><h5>Ultrasound </h5><p>Described sonographic features (whilst being non specific) include tumour with multi-locular cystic components and irregularly thickened septa and tumor walls or a solid tumor including several small cystic components <sup>5</sup>. </p><h5>Pelvic MRI</h5><p>Described signal characteristics include <sup>5</sup></p><ul>-<li>-<strong>T2</strong> :-<ul>-<li>signal intensities of the cystic components were high and those of the solid components were inhomogeneous, ranging from intermediate-high to high. </li>- +<p><strong>Sclerosing stromal tumour (SST) of the ovary</strong> is a rare ovarian neoplasm. It is considered a sub type of <a href="/articles/ovarian-stromal-tumour">ovarian stromal tumour</a>.</p><h4>Epidemiology</h4><p>It occurs predominantly in young women, peaks around 2<sup>nd</sup> to 3<sup>rd</sup> decades of life <sup>1-2</sup>. </p><h4>Clinical presentation</h4><p>Patients may have menstrual irregularity and/or pelvic pain <sup>4</sup>.</p><h4>Pathology</h4><p>It is histologically characterized by cellular heterogeneity, prominent vasculature, and a pseudolobular appearance composed of cellular and hypocellular areas. <span style="line-height:1.6em">They generally tend to be unilateral </span><sup style="line-height:1.6em">3</sup><span style="line-height:1.6em">.</span></p><h4>Radiographic features </h4><h5>Ultrasound </h5><p>Described sonographic features (whilst being non specific) include tumour with multi-locular cystic components and irregularly thickened septa and tumor walls or a solid tumor including several small cystic components <sup>5</sup>. </p><h5>Pelvic MRI</h5><p>Described signal characteristics include <sup>5</sup></p><ul>
- +<li>
- +<strong>T2</strong>: <ul>
- +<li>signal intensities of the cystic components were high and those of the solid components were inhomogeneous, ranging from intermediate-high to high</li>
-</li>- +</li>
-</li>-<li>-<strong>dynamic MRI</strong> : may show marked early enhancement of the solid components <sup>5,7</sup>.</li>-</ul><h4>See also</h4><ul><li><a href="/articles/ovarian-tumours" title="Ovarian tumours">ovarian tumours</a></li></ul>- +</li>
- +<li>
- +<strong>dynamic MRI</strong>: may show marked early enhancement of the solid components <sup>5,7</sup>
- +</li>
- +</ul><h4>See also</h4><ul><li><a href="/articles/ovarian-tumours">ovarian tumours</a></li></ul>